Analysis of Critical COVID-19 Cases Among Children in Korea

• Published in: Journal of Korean medical science Vol. 37; no. 1; p. e13
• Main Authors: Lee, Hyunju, Choi, Sujin, Park, Ji Young, Jo, Dae Sun, Choi, Ui Yoon, Lee, Heayon, Jung, Yun Tae, Chung, In Hyuk, Choe, Young June, Kim, Jin Yong, Park, Young-Joon, Choi, Eun Hwa
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Academy of Medical Sciences 03-01-2022; 대한의학회
• Subjects: Adolescent; Child; Child, Preschool; COVID-19 - complications; COVID-19 - epidemiology; COVID-19 - therapy; Critical Care; Female; Humans; Infant; Male; Original; Republic of Korea - epidemiology; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; 의학일반; Republic of Korea; COVID-19; Critical Care; Child; Korea
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2022.37.e13

Coronavirus disease 2019 (COVID-19) is generally asymptomatic or mild in otherwise healthy children, however, severe cases may occur. In this study, we report the clinical characteristics of children classified as critical COVID-19 in Korea to provide further insights into risk factors and management in children.
This study was a retrospective case series of children < 18 years of age classified as critical COVID-19. Cases were identified by the Korea Disease Control and Prevention Agency surveillance system and medical records were reviewed. Critical COVID-19 was defined as cases with severe illness requiring noninvasive (high flow nasal cannula, continuous positive airway pressure, or bilevel positive airway pressure) or invasive mechanical ventilation, extracorporeal membrane oxygenation (ECMO) or continuous renal replacement therapy (CRRT), between January 20, 2020 and October 7, 2021.
Among 39,146 cases diagnosed with COVID-19 in subjects < 18 years of age, eight cases (0.02%) were identified as critical COVID-19. The median age was 13 years (range 10 month-17 years) and male-to-female ratio was 1:1. Three children had underlying diseases; one child has asthma and major depressive disorder, one child had Lennox-Gastaut syndrome and one child had mental retardation and was newly diagnosed with type 2 diabetes mellitus with the diagnosis of COVID-19. Among the eight children, seven were obese (body mass index range [BMI] median 29.3, range 25.9-38.2, weight-for-length > 97% for infant) and one was overweight (BMI 21.3). All patients had fever, six patients had dyspnea or cough and other accompanied symptoms included sore throat, headache, lethargy and myalgia. Radiologic findings showed pneumonia within 1-8 days after symptom onset. Pneumonia progressed in these children for 2-6 days and was improved within 5-32 days after diagnosis. Among the eight critical cases, remdesivir was administered in six cases. Steroids were provided for all cases. Inotropics were administered in one case. Six cases were treated with noninvasive mechanical ventilator and three required mechanical ventilator. One case required ECMO due to acute respiratory distress syndrome. All cases were admitted to the intensive care unit and admission period ranged from 9-39 days. Among all critical COVID-19 cases < 18 years of age, there were no fatal cases.
To develop appropriate policies for children in the COVID-19 pandemic, it is important to monitor and assess the clinical burden in this population.